Improvement of chronic allograft nephropathy by reduction of calcineurin inhibitor and introduction of mycophenolic acid

被引：0
|
作者：
Merkel, Saskia [1 ]
Mengel, Michael [2 ]
Haller, Hermann [1 ]
Schwarz, Anke [1 ]
机构：
[1] Sch Med, Dept Nephrol, Hannover, Germany
[2] Sch Med, Dept Pathol, Hannover, Germany
来源：
TRANSPLANT INTERNATIONAL | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：238 / 238
页数：1
相关论文
共 50 条
  • [21] Conversion from calcineurin inhibitors to sirolimus in chronic allograft nephropathy: benefits and risks
    Diekmann, F
    Campistol, JM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) : 562 - 568
  • [22] DIFFERENCES IN MYCOPHENOLIC ACID AND METABOLITE, MYCOPHENOLIC ACID GLUCURONIDE EXPOSURES BETWEEN CALCINEURIN INHIBITOR REGIMENS POST-RENAL TRANSPLANT.
    Meaney, C.
    Sudchada, P.
    Consiglio, J.
    Wilding, G.
    Venuto, R.
    Tornatore, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S69 - S69
  • [23] Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation
    Kamar, Nassim
    Del Bello, Arnaud
    Belliere, Julie
    Rostaing, Lionel
    TRANSPLANT INTERNATIONAL, 2015, 28 (08) : 928 - 937
  • [24] DETECTION OF CHRONIC ALLOGRAFT NEPHROPATHY OTHER THAN CALCINEURIN INHIBITOR TOXICITY BY SERUM AND URINE BIOMARKERS IN STABLE KIDNEY TRANSPLANT PATIENTS
    Schupp, Lisa
    Hartmann, Bertram
    Keller, Frieder
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [25] Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy
    Aftali, B
    Shah, S
    Chowdhury, P
    O'Sullivan, H
    Taylor, J
    Goldsmith, D
    TRANSPLANTATION, 2005, 79 (03) : 304 - 309
  • [26] Regression of glomerulosclerosis in chronic allograft nephropathy following calcineurin inhibitors withdrawal and conversion to rapamycin
    Rossini, M.
    Stallone, G.
    Infante, B.
    Schena, A.
    Maiorano, A.
    Schena, F. P.
    Grandaliano, G.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 14 - 15
  • [27] CONVERSION FROM CALCINEURIN INHIBITORS TO SIROLIMUS IN ADVANCED STAGES OF CHRONIC ALLOGRAFT NEPHROPATHY: IS IT BENEFICIAL
    Moghadam, Ali Ghafari
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [28] A prospective randomised trial of mycophenolate mofetil and azathioprine after calcineurin reduction in renal allografts with established chronic allograft nephropathy.
    Brook, NR
    Metcalfe, MS
    Waller, JR
    Jain, S
    Hosgood, SA
    Nicholson, ML
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 485 - 485
  • [29] Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
    Diekmann, F
    Budde, K
    Oppenheimer, F
    Fritsche, L
    Neumayer, HH
    Campistol, JM
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1869 - 1875
  • [30] Long-term effects of a calcineurin-inhibitor-free immunosuppression with mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy
    Malyar, Viola
    Hohage, Helge
    Gerhardt, Ulf
    Suwelack, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 396 - 396
12345